Hisashi Uhara

5.3k citations
158 papers · 3.2k indexed · h-index 32
Topics
Cutaneous Melanoma Detection and Management (48 papers)Cancer Immunotherapy and Biomarkers (36 papers)CAR-T cell therapy research (33 papers)

In The Last Decade

Hisashi Uhara

145 papers receiving 3.1k citations

Peers

Hisashi Uhara
Comparison fields: 5 of 100
  • Oncology 2.1k
  • Dermatology 894
  • Epidemiology 873
  • Molecular Biology 829
  • Immunology 510
Replace E. Maubec with:
E. Maubec France
Lyn M. Duncan United States
Valerie A. White Canada
Doina Ivan United States
Massimo Mascolo Italy
Caterina Catricalà Italy
Priyadharsini Nagarajan United States
Kenji Kashima Japan
Edward T. Krementz United States
Carlos A. Torres‐Cabala United States
Hisashi Uhara relative to E. Maubec France E. Maubec's profile →
Citations per field
00.5×1.5×2.1×
E. Maubec · 1×
Citations per year

Countries citing papers authored by Hisashi Uhara

Since Specialization
Citations

This map shows the geographic impact of Hisashi Uhara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisashi Uhara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisashi Uhara more than expected).

Fields of papers citing papers by Hisashi Uhara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisashi Uhara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisashi Uhara. The network helps show where Hisashi Uhara may publish in the future.

Co-authorship network of co-authors of Hisashi Uhara

This figure shows the co-authorship network connecting the top 25 collaborators of Hisashi Uhara. A scholar is included among the top collaborators of Hisashi Uhara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisashi Uhara. Hisashi Uhara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 1
5 8
6 6
7 3
8 5
9 9
10 4
11 1
12 4
13 27
14 11
15 13
16 19
17 28
18 1
19 20
20 5

About Hisashi Uhara

Hisashi Uhara is a scholar working on Dermatology, Oncology and Immunology, having authored 158 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (48 papers), Cancer Immunotherapy and Biomarkers (36 papers) and CAR-T cell therapy research (33 papers). The work is most often cited by research in Dermatology (894 citations), Oncology (2.1k citations) and Epidemiology (873 citations). Hisashi Uhara has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshiaki Saida, Hiroshi Koga, Ryuhei Okuyama, Yoshio Kiyohara, Naoya Yamazaki, Hiroshi Uchi, Tatsuya Takenouchi, Satoshi Fukushima, Junji Kato and Minoru Takata. Their work appears in journals such as Journal of Clinical Oncology, Neurology and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026